CRH, ACTH, and Cortisol: The Peptide Feedback Loop

ACTH-Cortisol Axis

41 amino acids

CRH is a 41-amino-acid peptide that launches the entire cortisol cascade from the hypothalamus, identified by Wylie Vale's lab in 1981.

Vale et al., Science, 1981

Vale et al., Science, 1981

View as image

Three peptides, three organs, one loop. Corticotropin-releasing hormone (CRH) fires from the hypothalamus, adrenocorticotropic hormone (ACTH) fires from the pituitary, and cortisol fires from the adrenal glands. Then cortisol reaches back up to shut the whole system down. This negative feedback loop, called the hypothalamic-pituitary-adrenal (HPA) axis, is how the body mounts and then terminates its stress response. Every component is a peptide or is directly controlled by one, and when the loop breaks, the consequences show up as clinical disease. For a broader view of the axis, see our pillar article on the ACTH-cortisol axis.

Step 1: CRH launches the cascade

The feedback loop begins in the paraventricular nucleus (PVN) of the hypothalamus. When the brain detects a threat, whether physical danger, infection, pain, or psychological stress, neurons in the PVN release CRH into the hypophyseal portal blood system. This specialized vascular network carries CRH directly from the hypothalamus to the anterior pituitary, a distance of just a few millimeters but a journey that triggers a body-wide hormonal response.

CRH is a 41-amino-acid peptide that binds to CRF1 receptors on corticotroph cells in the anterior pituitary.^[4] CRF1 and CRF2 receptors serve distinct roles. CRF1 activation drives the acute stress response: anxiety, arousal, and ACTH release. CRF2, preferentially activated by related peptides called urocortins, appears to mediate stress recovery and anxiolytic effects.^[4] This dual receptor system means the CRF peptide family both starts and helps resolve the stress response.

CRH does not work alone at the pituitary. Arginine vasopressin (AVP), released from the same PVN neurons, acts synergistically with CRH to amplify ACTH release. The relative contribution of AVP increases during chronic or repeated stress, shifting the signaling balance away from CRH-dominant control.

Step 2: ACTH is cleaved from POMC

When CRH activates corticotroph cells, they do not simply release a pre-stored ACTH molecule. Instead, CRH triggers proteolytic cleavage of a large precursor protein called proopiomelanocortin (POMC). This 241-amino-acid precursor is the single most versatile peptide precursor in the body. From one POMC molecule, the cell generates ACTH (39 amino acids), beta-endorphin (31 amino acids), alpha-melanocyte-stimulating hormone (alpha-MSH), and several other bioactive fragments.

The fact that ACTH and beta-endorphin come from the same precursor has functional implications. Every time the stress axis fires and ACTH is cleaved from POMC, beta-endorphin is co-released.^[8] This couples the stress response to the opioid pain-modulation system. It is one reason why acute stress can temporarily suppress pain perception, a phenomenon called stress-induced analgesia. Beta-endorphin then feeds back to regulate its own precursor: in rat hypothalamic cultures, beta-endorphin inhibited POMC mRNA by 65% through delta opioid receptors.^[8]

Once released into the bloodstream, ACTH travels to the adrenal cortex, where it binds melanocortin-2 receptors (MC2R) on cells in the zona fasciculata. This binding triggers the synthesis and secretion of cortisol (in humans) or corticosterone (in rodents). For a dedicated breakdown of this step, see ACTH: the peptide that tells your adrenals to make cortisol.

Step 3: Cortisol completes the loop

Cortisol, a steroid hormone, is the final effector of the HPA axis. It mobilizes glucose, suppresses inflammation, shifts immune function, and alters cognition. But its most critical role in maintaining the loop is negative feedback: cortisol suppresses further CRH and ACTH release at multiple levels.

This feedback operates at two distinct speeds.

Fast feedback (seconds to minutes). Cortisol rapidly inhibits CRH secretion from the PVN and ACTH secretion from pituitary corticotrophs through nongenomic mechanisms. This does not require gene transcription. Instead, cortisol binds membrane-associated receptors and directly suppresses neuropeptide release. This fast brake prevents runaway activation during acute stress.

Slow feedback (hours to days). Cortisol enters the nucleus, binds glucocorticoid receptors (GR), and suppresses transcription of the CRH gene in the hypothalamus and the POMC gene in the pituitary.^[3] This genomic action reduces the total pool of CRH and ACTH precursor available for future stress responses. Fuxe and colleagues showed in 1991 that glucocorticoid receptors are present on virtually all CRH, GRF, TRH, and somatostatin neurons in the paraventricular nucleus, confirming that cortisol has direct genomic access to the neurons it needs to suppress.^[3]

Two receptor types mediate cortisol feedback. Mineralocorticoid receptors (MR), which have high affinity for cortisol, are occupied at basal cortisol levels and help maintain the circadian rhythm. Glucocorticoid receptors (GR), which have lower affinity, are recruited only when cortisol is elevated during stress, providing the active brake that shuts down the axis.

The feedback loop is not limited to the hypothalamus and pituitary. The hippocampus, rich in both MR and GR, is a major upstream regulator. Hippocampal activation inhibits the PVN. Chronic stress damages hippocampal neurons, weakens this inhibitory input, and disinhibits the HPA axis, creating a vicious cycle where stress breeds more stress.

CRH reaches beyond the adrenal axis

CRH fibers do not all project to the median eminence for transport to the pituitary. A substantial proportion terminate within the hypothalamus itself, forming synaptic connections with other neuropeptide neurons. Calogero's 1993 work demonstrated that CRH is a potent stimulator of all three major endogenous opioid peptides: beta-endorphin, met-enkephalin, and dynorphin.^[2] CRH stimulates opioid neurons tonically, meaning this is not just an acute stress effect but an ongoing modulation.

For beta-endorphin specifically, CRH's effect requires an intermediary: arginine vasopressin appears essential for CRH to stimulate beta-endorphin release, suggesting CRH acts through vasopressin neurons rather than directly on POMC neurons.^[2]

CRH also inhibits gonadotropin-releasing hormone (GnRH) secretion, both directly and through opioid intermediaries. This connection explains why chronic stress suppresses reproductive function. The stress axis literally borrows resources from the reproductive axis. The broader role of CRH as a brain-wide stress coordinator is covered in CRH: the stress peptide that launches the cortisol cascade.

The CRF peptide family extends the system

CRH is not the only member of its peptide family. Three urocortins (Ucn I, Ucn II, and Ucn III) were discovered between 1995 and 2001, each with different receptor preferences.^[5] Ucn II and Ucn III are selective CRF2 agonists. Because CRF2 activation appears to promote stress recovery rather than stress initiation, these peptides may represent the body's built-in system for returning to baseline after the acute threat has passed.

The CRF family also operates in peripheral tissues. CRF1 and CRF2 receptors are expressed on immune cells, in the gastrointestinal tract, in skin, and in the reproductive system.^[5] CRF1 activation tends to be pro-inflammatory (stimulating mast cell degranulation, increasing gut motility, promoting local inflammation), while CRF2 activation tends to be anti-inflammatory. This peripheral CRF system explains why stress exacerbates inflammatory conditions like irritable bowel syndrome, eczema, and rheumatoid arthritis without requiring cortisol as the sole mediator.

Peptides that oppose the loop

The HPA axis does not operate in isolation. Multiple peptide systems restrain or modulate it.

Neuropeptide Y (NPY) is the most studied HPA antagonist. Antonijevic and colleagues showed in 2000 that intravenous NPY in young men reduced ACTH secretion during the first half of the night and cortisol secretion during the second half, while simultaneously promoting sleep and reducing sleep latency.^[6] NPY's anxiolytic and sedative effects are thought to involve direct inhibition of CRH neurons, essentially putting a brake on the brake's accelerator. This positions NPY as a stress resilience peptide with therapeutic potential for conditions involving HPA hyperactivation.

Endogenous opioid peptides provide another layer of modulation. Beta-endorphin, co-released with ACTH from POMC, feeds back to suppress further POMC transcription.^[8] Adrenal enkephalins are co-secreted with catecholamines from the adrenal medulla during stress, adding opioid modulation from the adrenal side. The relationship between the stress axis and the body's natural painkiller system runs deep.

DSIP (delta sleep-inducing peptide) may also interact with the HPA axis, modulating cortisol rhythms and stress responses beyond its sleep effects.

What happens when the loop breaks

When negative feedback fails, the results are clinically recognizable.

Cushing's syndrome occurs when cortisol stays chronically elevated and fails to suppress ACTH and CRH. In Cushing's disease (pituitary adenoma), a tumor produces ACTH autonomously, ignoring cortisol feedback. In ectopic ACTH syndrome, a non-pituitary tumor secretes ACTH. Korbonits and colleagues demonstrated that even ectopic ACTH-producing tumors can express GHS receptors, making them responsive to GHRP-6 testing as a diagnostic tool.^[9]

Addison's disease is the opposite: the adrenal glands fail to produce cortisol. Without cortisol feedback, CRH and ACTH rise unchecked. POMC cleavage accelerates, and excess ACTH fragments with melanocyte-stimulating activity cause the characteristic skin darkening.

Major depression involves a subtler but well-documented HPA axis disruption. Nemeroff's landmark 1988 work found elevated CRF concentrations in the cerebrospinal fluid of drug-free depressed patients.^[1] In post-mortem studies of suicide victims, CRF receptor density in the frontal cortex was reduced, consistent with downregulation from chronic CRF hypersecretion. The behavioral effects of excess central CRF (diminished appetite, disrupted sleep, reduced sexual behavior, altered locomotor activity) mirror the symptom profile of major depression remarkably closely.^[1] This connection between CRF and depression has driven decades of CRF1 antagonist drug development.

Post-traumatic stress disorder (PTSD) presents a paradox: cortisol levels are often low despite HPA activation. This may reflect enhanced negative feedback sensitivity, where the system over-corrects rather than under-corrects. The result is an axis that responds explosively to stress cues but suppresses cortisol too aggressively afterward.

Chronic stress produces a different kind of damage. Sustained HPA activation shifts the system's set point. Chronic CRH hypersecretion downregulates CRF1 receptors, reducing the pituitary's sensitivity to CRH. Simultaneously, the hippocampus, which normally restrains the PVN, loses neurons under prolonged glucocorticoid exposure. This hippocampal atrophy weakens the brake on the HPA axis, producing a feed-forward loop: chronic stress reduces the brain's ability to terminate the stress response, leading to more chronic stress. These structural changes can persist long after the original stressor resolves, which partly explains why recovery from burnout or prolonged adversity takes months rather than days.

Growth hormone secretagogues interact with the loop

The HPA axis overlaps with the growth hormone axis at the receptor level. GHRP-2 and hexarelin, two growth hormone secretagogues, both stimulate ACTH and cortisol release in addition to GH.^[7] Arvat and colleagues showed in 1997 that the ACTH and cortisol responses to GHRP-2 and hexarelin were comparable in magnitude to those produced by human CRH itself.^[7] This cross-activation has clinical utility: the GHRP-6 test is used diagnostically to differentiate pituitary from ectopic Cushing's syndrome.^[9]

The Bottom Line

The CRH-ACTH-cortisol feedback loop is the body's core stress management circuit. CRH from the hypothalamus triggers ACTH cleavage from POMC in the pituitary, ACTH drives cortisol synthesis in the adrenals, and cortisol feeds back to suppress both CRH and ACTH through fast and slow mechanisms. The loop interconnects with opioid peptides, neuropeptide Y, the reproductive axis, and the immune system. When the feedback fails, the clinical consequences include Cushing's syndrome, Addison's disease, and major depression.

Frequently Asked Questions

What is the CRH ACTH cortisol feedback loop?

The CRH-ACTH-cortisol feedback loop is the body's primary stress response circuit. CRH (corticotropin-releasing hormone) is released from the hypothalamus and triggers ACTH release from the pituitary. ACTH then stimulates cortisol production from the adrenal glands. Cortisol feeds back to suppress both CRH and ACTH, creating a self-limiting negative feedback loop that prevents uncontrolled stress hormone production.

How does cortisol inhibit CRH and ACTH?

Cortisol inhibits CRH and ACTH through two mechanisms operating at different speeds. Fast feedback (within seconds to minutes) uses nongenomic signaling to rapidly suppress CRH and ACTH secretion. Slow feedback (hours to days) involves cortisol entering cell nuclei and suppressing transcription of the CRH gene in the hypothalamus and the POMC gene (ACTH's precursor) in the pituitary.

What happens when the HPA axis feedback loop fails?

When HPA axis feedback fails, clinical disease results. If cortisol stays high and cannot suppress ACTH (as in Cushing's syndrome), the body suffers metabolic damage, weight gain, and immune suppression. If cortisol production fails (Addison's disease), CRH and ACTH rise unchecked, causing fatigue and the characteristic skin darkening from excess ACTH fragments.

Is ACTH a peptide hormone?

ACTH is a 39-amino-acid peptide hormone produced by corticotroph cells in the anterior pituitary gland. It is cleaved from a larger precursor protein called proopiomelanocortin (POMC), which also produces beta-endorphin and alpha-MSH. ACTH travels through the blood to the adrenal cortex, where it stimulates cortisol synthesis by binding melanocortin-2 receptors.

What is the role of CRH in the stress response?

CRH (corticotropin-releasing hormone) is the 41-amino-acid peptide that initiates the entire stress response cascade. Released from the hypothalamic paraventricular nucleus, it triggers ACTH secretion from the pituitary. Beyond the adrenal axis, CRH also modulates opioid peptide release, inhibits reproductive function, and acts as a neurotransmitter in brain regions controlling anxiety and arousal.

Does depression affect the HPA axis?

Depression involves documented HPA axis dysfunction. Nemeroff's 1988 research found elevated CRF concentrations in the cerebrospinal fluid of depressed patients and reduced CRF receptor density in suicide victims' brains. Chronic CRF hypersecretion produces symptoms that mirror depression: disrupted sleep, reduced appetite, diminished sexual behavior, and altered activity levels.